87 related articles for article (PubMed ID: 12152666)
1. Plasmin/alpha2-antiplasmin complexes (PAP) in lung cancer patients: effects of radiotherapy.
Uszyński M; Ziółkowska E; Zekanowska E; Uszyński W
Thromb Haemost; 2002 Jul; 88(1):169-70. PubMed ID: 12152666
[No Abstract] [Full Text] [Related]
2. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinolysis parameters: plasmin-alpha2 antiplasmin complexes (PAP) and D-dimers in acute coronary syndromes without ST segment elevation].
Grabarczyk E; Wodyńska T; Kotschy M
Pol Merkur Lekarski; 2004 Dec; 17(102):555-7. PubMed ID: 15771120
[TBL] [Abstract][Full Text] [Related]
4. [Plasmin-alpha 2-antiplasmin complexes in blood of patient with lichen planus against the background of other fibrinolysis parameters].
Wankiewicz A; Iwan-Zietek I; Kotschy M; Zwolska A
Pol Merkur Lekarski; 2003 Jul; 15(85):72-4. PubMed ID: 14593965
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocyte receptors for proteinase inhibitor complexes with plasmin].
Zorin NA; Zhabin SG; Gorin VS
Tsitologiia; 1993; 35(2):55-9. PubMed ID: 7686697
[TBL] [Abstract][Full Text] [Related]
6. Breast cyst fluid plasmin activity and its effect on TGF-beta2 activation.
Erbas H; Erten O; Irfanoglu ME
Cancer Invest; 2008 Feb; 26(1):22-7. PubMed ID: 18181041
[TBL] [Abstract][Full Text] [Related]
7. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
Christensen U; Bangert K; Thorsen S
FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
[TBL] [Abstract][Full Text] [Related]
8. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
[TBL] [Abstract][Full Text] [Related]
9. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
Hayashi M; Hamada Y; Ohkura T
Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
[No Abstract] [Full Text] [Related]
11. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
12. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
Bouma B; Maas C; Hazenberg BP; Lokhorst HM; Gebbink MF
J Thromb Haemost; 2007 Jun; 5(6):1139-42. PubMed ID: 17371485
[No Abstract] [Full Text] [Related]
13. [Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis].
Iwamoto M; Sugiyama N
Rinsho Byori; 1989 Apr; Spec No 81():118-25. PubMed ID: 2526883
[No Abstract] [Full Text] [Related]
14. [On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (Ipsilon) administration].
YAMASHITA H; IGARI S; TANAKA T
Nihon Igaku Hoshasen Gakkai Zasshi; 1961 Sep; 21():646-55. PubMed ID: 14008906
[No Abstract] [Full Text] [Related]
15. Changes in antiplasmin and plasmin activities during extreme hemodilution and open heart surgery in dogs.
Aasen AO; Gallimore MJ; Lilleaasen P; Lyngaas K; Larsbraaten M; Amundsen E
Eur Surg Res; 1979; 11(3):145-53. PubMed ID: 159822
[TBL] [Abstract][Full Text] [Related]
16. On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
YAMASHITA H; IGARI S; TANAKA T
Keio J Med; 1961 Dec; 10():195-207. PubMed ID: 14008905
[No Abstract] [Full Text] [Related]
17. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma.
Montes R; Páramo JA; Anglès-Cano E; Rocha E
Br J Haematol; 1996 Mar; 92(4):979-85. PubMed ID: 8616097
[TBL] [Abstract][Full Text] [Related]
18. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
19. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
Biagini D; Filippucci E; Agnelli G; Pagliaricci S
Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
[TBL] [Abstract][Full Text] [Related]
20. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
